National Pharmaceutical Pricing Authority notifies retail prices of 41 new drugs: Gireesh Babu, New Delhi Thursday, June 5, 2025, 08:00 Hrs [IST] The National Pharmaceutical Prici ...

Agenus will give Zydus an exclusive licence for the development and commercialisation of BOT and BAL in Sri Lanka and India.

Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Rifaximin tablets are indicated for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. The tablets ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus ...

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. These tables are also intended ...

(Image: Freepik) Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture Apalutamide Tablets, 60 mg. However, the stock came ...

The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...

OnePlus may be working on a powerful new tablet that could launch this year. The new tablet is reportedly the OnePlus Pad 2 Pro. Specs for the beastly new tablet were shared by regular leaker ...

The tablets will be manufactured at the company ... and regulatory preclinical toxicology studies for this combination vaccine. Zydus Lifesciences had reported a 30 percent increase in its ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine. The project is expected to get underway in ...